| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Damora Therapeutics, Inc. (DMRA) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 1 sell. DMRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 500.0K | $14.94M | - | |
| Dir | 37.3K | $1.11M | - | |
| Dir | 37.3K | $1.11M | - | |
| 10% | 37.3K | $1.11M | - | |
| Dir | 37.3K | $1.11M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Winslow Garrett | General Counsel | Sale+OE | 245 | $29.98 | $7,345.10 | -9.7% | - | - |